← Back to directory

Lars Eckardt

Researcher Next ID · RN-034253

Researcher · Biochemistry, Genetics and Molecular Biology

Klinik und Poliklinik für Psychosomatik und Psychotherapie

Cologne, Switzerland

Accepting doctoral researchersFunding unknown
Works count
822
Citation count
28,005
H-index
71
i10-index
337

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Cardiac Arrhythmias and Treatments
Cardiac electrophysiology and arrhythmias
Atrial Fibrillation Management and Outcomes
Cardiac pacing and defibrillation studies
Ion channel regulation and function

Publications

  • 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

    European Heart Journal · 2024 · https://doi.org/10.1093/eurheartj/ehae176

  • A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study

    European Heart Journal · 2023 · 10.1093/eurheartj/ehad250

  • Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference

    EP Europace · 2022 · https://doi.org/10.1093/europace/euac062

  • 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

    European Heart Journal · 2022 · https://doi.org/10.1093/eurheartj/ehac262

  • Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper

    EP Europace · 2022 · https://doi.org/10.1093/europace/euac144

  • Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial

    European Heart Journal · 2021 · 10.1093/eurheartj/ehab593

  • Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure

    Circulation · 2021 · 10.1161/circulationaha.121.056323

  • Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

    New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2019422

  • Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT)

    Circulation · 2020 · 10.1161/circulationaha.119.043400

  • Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial

    Circulation · 2020 · 10.1161/circulationaha.120.048728

  • Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

    The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)31872-0

  • Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials

    European Heart Journal · 2019 · 10.1093/eurheartj/ehz732

  • Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry

    Journal of the American College of Cardiology · 2017 · 10.1016/j.jacc.2017.06.040

  • Predictors of Atrial Fibrillation Recurrence after Catheter Ablation: Data from the German Ablation Registry

    Scientific Reports · 2017 · 10.1038/s41598-017-16938-6

  • Impact of Complete Versus Incomplete Circumferential Lines Around the Pulmonary Veins During Catheter Ablation of Paroxysmal Atrial Fibrillation

    Circulation Arrhythmia and Electrophysiology · 2016 · https://doi.org/10.1161/circep.115.003337

  • Occult Atrial Fibrillation in Cryptogenic Stroke

    Stroke · 2013 · 10.1161/strokeaha.111.676189

  • Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial

    The Lancet · 2010 · https://doi.org/10.1016/s0140-6736(09)61755-4

  • Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome

    Circulation · 2010 · https://doi.org/10.1161/circulationaha.109.887026

  • Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data

    European Heart Journal · 2007 · 10.1093/eurheartj/ehm116

  • A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification

    European Heart Journal · 2006 · 10.1093/eurheartj/ehl205

  • Long-Term Prognosis of Individuals With Right Precordial ST-Segment–Elevation Brugada Syndrome

    Circulation · 2005 · 10.1161/01.cir.0000153267.21278.8d

  • Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: Different incidences in familial and sporadic disease

    Human Mutation · 2003 · 10.1002/humu.9144

  • Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non–SCN5A-related patients

    Journal of the American College of Cardiology · 2002 · 10.1016/s0735-1097(02)01962-9

  • Cardiac Autonomic Dysfunction in Brugada Syndrome

    Circulation · 2002 · 10.1161/hc0602.103677

  • Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial

    The Lancet · 2002 · 10.1016/s0140-6736(02)11315-8

  • Divergent Proarrhythmic Potential of Macrolide Antibiotics Despite Similar QT Prolongation: Fast Phase 3 Repolarization Prevents Early Afterdepolarizations and Torsade de Pointes

    Journal of Pharmacology and Experimental Therapeutics · 2002 · 10.1124/jpet.102.037911

Current projects

    No projects listed.